Clinical Trial

PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer

Name: PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer — clinical trial record (NCT07460726)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PRIAPUS-PCa

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study looks at how combined radiation and hormone therapy affects sexual function in men with a specific type of prostate cancer, before and after treatment.

Trial Details

NCT Number	NCT07460726
Lead Sponsor	CancerCare Manitoba Collaborators: TerSera Therapeutics LLC
Conditions	Prostate Cancer (Adenocarcinoma), Erectile Abnormalities, Sexual Dysfunction Male
Enrollment	130 participants
Start Date	2026-03-16
Primary Completion	2028-03-16 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-10